Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

EMILIN-1-related connective tissue disease News | Kisho

Kisho

Not rare diseases news,
news about your rare disease.

Earlier

This 'living drug' could change the course of autoimmune disease

A systematic literature review highlights the importance of early detection and treatment initiation in improving long-term health outcomes for patients with connective tissue disease-associated pulmonary arterial hypertension. Expert consensus emphasizes the need for enhanced screening protocols.

A rare disease, a good result: Researchers report positive Phase 3 trial results for a treatment for dermatomyositis | AAD 2026 | Managed Healthcare Executive

A recent study published in PubMed highlights the extended follow-up of CD19 CAR T-cell therapy in patients with connective tissue disease-associated pulmonary arterial hypertension. This research contributes to understanding the potential of CAR T-cell therapy in rare diseases.

An analysis of clinical manifestations and therapeutic outcomes in pediatric connective tissue disease-associated interstitial lung disease.

Not rare diseases news,news about your rare disease.

Earlier

This 'living drug' could change the course of autoimmune disease

A systematic literature review highlights the importance of early detection and treatment initiation in improving long-term health outcomes for patients with connective tissue disease-associated pulmonary arterial hypertension. Expert consensus emphasizes the need for enhanced screening protocols.

A rare disease, a good result: Researchers report positive Phase 3 trial results for a treatment for dermatomyositis | AAD 2026 | Managed Healthcare Executive

A recent study published in PubMed highlights the extended follow-up of CD19 CAR T-cell therapy in patients with connective tissue disease-associated pulmonary arterial hypertension. This research contributes to understanding the potential of CAR T-cell therapy in rare diseases.

An analysis of clinical manifestations and therapeutic outcomes in pediatric connective tissue disease-associated interstitial lung disease.

Not rare diseases news,
news about your rare disease.